Secondary Prevention of Venous Thrombo Embolism (VTE).

Pas encore traduit Pas encore traduit
Auteurs
Catégorie Primary study
Registry of Trialsclinicaltrials.gov
Year 2006

This article is not included in any systematic review

This article is part of the following publication threads:
  • RE-MEDY [Secondary Prevention of Venous Thrombo Embolism (VTE)] (2 documents)
Loading references information
The general aim of this study is to determine the comparative safety and efficacy of dabigatran etexilate administered orally and warfarin (International Normalized Ratio (INR) of 2.0-3.0) for the long-term treatment and secondary prevention of symptomatic venous thromboembolism in patients who have been successfully treated with standard doses of an approved anticoagulant for three to twelve months for confirmed acute symptomatic Venous Thrombo-embolism.
Epistemonikos ID: b3e713c4725a172fce8a7f032f15bee01e01a0bb
First added on: Mar 23, 2015